Gefticip Gefitinib – 250 mg (1 pack / 30 tablets)

Buy Gefticip 250 mg Gefitinib Tablets Online

Gefticip Gefitinib – 250 mg (1 pack / 30 tablets)

At a Glance

Generic Name: Gefitinib

Brand Name: Gefticip

Strength & Pack Size: 250 mg tablets – 1 pack / 30 tabs

Dosage Form: Oral film-coated tablets

Therapeutic Class: EGFR tyrosine kinase inhibitor, targeted anticancer therapy

Main Indication: Advanced or metastatic non-small cell lung cancer (NSCLC) with sensitising EGFR mutations

Use in Therapy: First-line or subsequent-line targeted treatment under specialist oncology guidance

Prescription Status: Prescription-only oncology medicine

Supplied By: Licensed manufacturers and authorised distributors

Storage: Store below 25 °C in a dry place, protected from light and moisture

Product Description

Gefticip 250 mg is a gefitinib tablet used as targeted therapy in selected patients with advanced or metastatic
non-small cell lung cancer (NSCLC). Many NSCLC tumours, especially adenocarcinomas, carry activating
EGFR mutations that make tumour cells depend heavily on EGFR signalling for growth and survival.
Gefticip 250 mg gefitinib tablets are designed to inhibit this pathway and help slow disease progression in EGFR-mutation–positive lung cancer
under the supervision of an experienced oncology team.

Each Gefticip tablet contains 250 mg gefitinib, the standard oral dose used in most gefitinib protocols.
The 1 pack / 30 tablets presentation usually corresponds to about one month of once-daily treatment, making it simple to align
Gefticip orders with monthly visits and imaging. As a generic gefitinib 250 mg product, Gefticip offers the same active ingredient and strength
as originator gefitinib while often being more accessible in USD, which is important when targeted therapy is required for many months.

Gefticip 250 mg gefitinib tablets are normally prescribed only after molecular testing has confirmed that the tumour carries a sensitising EGFR mutation.
In some settings, Gefticip is used as first-line systemic therapy in EGFR-positive NSCLC; in others it may be prescribed after chemotherapy, depending on guidelines.
Generic Meds Mart does not decide whether you should receive gefitinib; we supply Gefticip 250 mg in the pack size and quantity that match your written treatment plan.

Key Uses

Gefticip 250 mg gefitinib tablets are typically used under specialist supervision for:

• Advanced or metastatic non-small cell lung cancer (NSCLC), usually adenocarcinoma, with documented sensitising EGFR mutations
• First-line targeted therapy in EGFR-mutation–positive NSCLC where gefitinib is recommended by current guidelines
• Subsequent-line targeted therapy in selected patients whose disease remains suitable for EGFR inhibitor treatment

Your oncologist will decide whether Gefticip 250 mg is appropriate based on EGFR mutation status, prior therapies and overall clinical status.

How Gefitinib Works in Chemotherapy

Gefitinib is a targeted anticancer medicine from the class of EGFR tyrosine kinase inhibitors.
Unlike classic cytotoxic chemotherapy, Gefticip gefitinib does not directly damage DNA.
Instead, it selectively blocks the intracellular tyrosine kinase activity of the epidermal growth factor receptor (EGFR).

In EGFR-positive NSCLC, constitutively active EGFR triggers downstream signalling through pathways such as RAS/RAF/MEK/ERK and PI3K/AKT,
promoting tumour cell survival and proliferation. By binding to the ATP-binding site of the EGFR tyrosine kinase,
Gefticip 250 mg reduces receptor phosphorylation and interrupts these downstream signals.
This deprives tumour cells of proliferative and anti-apoptotic signals, making them more likely to slow growth or undergo programmed cell death.

Because EGFR is also present in normal tissues, especially skin and gastrointestinal epithelium,
gefitinib therapy can lead to class-typical side effects such as rash and diarrhea, which require regular monitoring and supportive care.

Dosage & Administration

The dose and schedule of Gefticip 250 mg must always be set by your oncology team based on current guidelines and your individual situation.
In many protocols, the usual adult dose is one Gefticip 250 mg tablet taken once daily, but only your treating specialists can confirm the correct regimen.

• Take Gefticip tablets once daily at roughly the same time each day, with a glass of water.
• Swallow Gefticip 250 mg whole; do not crush, split or chew the tablet unless your pharmacist provides specific instructions.
• Follow your clinic’s advice on taking gefitinib with or without food and keep a consistent routine.
• Do not change your daily dose, stop treatment or take extra tablets without clear guidance from your oncology team.
• If you miss a dose, follow written instructions from your treatment centre; do not double the next dose unless your doctor tells you to.

Regular visits, blood tests and imaging help your doctors assess response and decide whether your dose of Gefticip 250 mg gefitinib should continue or be adjusted.

Precautions

Before starting Gefticip 250 mg gefitinib tablets, inform your healthcare team about your full medical history and all medicines, supplements and herbal products you use.
Key precautions include:

• Pre-existing liver disease or abnormal liver function tests
• History of interstitial lung disease, pulmonary fibrosis or chronic lung conditions
• Use of strong CYP3A4 inducers or inhibitors that may alter gefitinib blood levels
• Use of gastric acid–reducing medicines that can affect gefitinib tablet absorption
• Pregnancy or breastfeeding; Gefticip gefitinib is not recommended and may harm an unborn baby

Men and women of reproductive potential are usually advised to use reliable contraception during and for a period after Gefticip 250 mg therapy, as directed by their oncologist.

Gefitinib Side Effects

Common side effects

Common side effects of Gefticip 250 mg gefitinib tablets can include:

• Acne-like skin rash on the face, scalp and upper torso
• Dry skin, itching or mild redness
• Diarrhea or loose stools
• Nausea, occasional vomiting or reduced appetite
• Mild mouth sores or irritation in the mouth or throat
• Fatigue or low energy
• Mild elevations in liver enzymes on blood tests

These effects are often manageable with supportive care, dermatologic treatments and, when necessary, dose adjustments as decided by your oncology team.

Serious side effects

Less common but serious side effects of gefitinib require urgent medical attention and may include:

• New or rapidly worsening shortness of breath, cough and fever suggesting interstitial lung disease or severe pneumonitis
• Signs of serious liver injury: yellowing of the skin or eyes, dark urine, pale stools, persistent upper abdominal pain
• Severe or prolonged diarrhea leading to dehydration
• Severe skin reactions with blistering, peeling or painful widespread rash
• Sudden chest pain, severe breathlessness or other acute symptoms suggesting cardiovascular or pulmonary complications

If you experience any of these symptoms while taking Gefticip 250 mg, seek emergency medical care immediately and contact your oncology team.

Storage

• Store Gefticip 250 mg gefitinib tablets at room temperature, preferably below 25 °C.
• Keep tablets in their original blisters and outer carton, protected from moisture and light.
• Keep all anticancer medicines out of the sight and reach of children and pets.
• Do not use Gefticip after the expiry date printed on the packaging.

Ask your pharmacist how to safely dispose of unused or expired Gefticip gefitinib tablets.

Why Buy from Generic Meds Mart

Generic Meds Mart provides safe, structured access to key oncology medicines such as
Gefticip 250 mg gefitinib tablets at transparent prices in USD.
We source only from licensed manufacturers and authorised distributors that comply with recognised GMP standards and maintain a reliable export record.

When you buy Gefticip online from Generic Meds Mart, you benefit from:

• Original gefitinib 250 mg blisters and cartons from licensed suppliers
• Discreet, plain outer packaging for international delivery
• Tracked shipping options to many destinations
• Clear, structured information about Gefticip gefitinib tablets to support discussions with your oncology team
• Support for ordering, payment and delivery questions

Order Now

Gefticip 250 mg gefitinib tablets are prescription-only targeted anticancer medicines and must be used strictly under specialist supervision.
Before you order Gefticip online, ensure your oncologist has confirmed an EGFR-mutation–positive tumour, recommended gefitinib as part of your treatment plan and specified the daily dose and duration.

Select Gefticip 250 mg (1 pack / 30 tablets), choose the quantity that matches your written plan, add it to your cart and complete the secure checkout on Generic Meds Mart.
Your order will be processed, packed discreetly and shipped with tracking where available. All treatment decisions and dose adjustments must remain with your healthcare team.